Tschochner, Monika - University of Notre Dame Australia

研究领域

Human Anatomy and Physiology Pathology Genetics

近期论文

查看导师新发文章（温馨提示：请注意重名现象，建议点开原文通过作者单位确认）

Tschochner, M., Leary, S., Cooper, D., Strautins, K., Chopra, A., Clark, H., Choo, L., Dunn, D., James, I., Carroll, W.M., Kermode, A.G., Nolan, D. (2016). Identifying patient-specific Epstein-Barr Nuclear antigen-1 genetic variation and potential autoreactive targets relevant to multiple sclerosis pathogenesis. PLoS One. Strautins K, Tschochner M, James I, Choo L, Dunn DS, Pedrini M, Kermode A, Carroll W, Nolan D. Combining HLA-DR and anti-Epstein-Barr antibody profiles to stratify multiple sclerosis risk. Multiple Sclerosis Journal, 2014, Mar;20(3):286-94. Epub 2013 Jul 25. Nolan D, Castley A, Tschochner M, James I, Qiu W, Sayer D, Christiansen F, Witt C, Mastaglia F, Carroll W, Kermode A. Contributions of Vitamin D response elements and HLA promoters to multiple sclerosis risk. Neurology, 2012, Aug 7;79(6):538-46. Epub 2012 Jul 11. Keane NM, Roberts SG, Almeida CM, Krishnan T, Chopra A, Demaine E, Laird R, Tschochner M, Carlson JM, Mallal S, Heckerman D, James I, John M. High-avidity, high-IFNγ-producing CD8 T-cell responses following immune selection during HIV-1 infection. Immunol Cell Biol. 2012 Feb; 90(2):224-34. Epub 2011 May 17. Weisser H, Altmann A, Sierra S, Incardona F, Struck D, Sönnerborg A, Kaiser R, Zazzi M, Tschochner M, Walter H, Lengauer T. Only slight impact of predicted replicative capacity for therapy response prediction. 3; 5(2):e9044. PLoS One 2010. Tschochner M, Chopra A, Maiden TM, Ahmad IF, James I, Furrer H, Günthard HF, Mallal S, Rauch A, John M. Effects of HIV-1 Immune Selection on Susceptability to Integrase Inhibitor Resistance. Antivir Ther. 2009, 14:953-964. Tschochner M, Schwingel E, Thein C, Wittmann S, Paatz C, Walter H. Superiority of Infectivity-Based over Particle-Based Methods for Quantitation of Drug Resistant HIV-1 as Inocula for Cell Cultures. J. Virol. Methods. 2007 Apr, 141(1):87-96. Epub 2006 Dec 28. Walter H, Low P, Harrer T, Schmitt M, Schwingel E, Tschochner M, Helm M, Korn K, Überla K, Schmidt B. No Evidence for Persistence of Multidrug-Resistant Viral Strains after a 7-Month Treatment Interruption in an HIV-1-Infected Individual. J Acquir Immune Defic Syndr. 2002 Oct 1;31(2):137-46.